Quick Facts
- Status: First FDA-cleared OTC glucose biosensor.
- Lifespan: 15-day wear per sensor.
- Target: Non-insulin Type 2 diabetics and prediabetics (18+).
- Frequency: Updates every 15 minutes.
- Cost: Approximately $99 per month.
- Durability: Waterproof up to 8 feet for 24 hours.
- Payment: HSA and FSA eligible.
The Dexcom Stelo CGM is an over-the-counter continuous glucose biosensor designed for adults 18 and older who do not use insulin. This wearable device features a 15-day sensor that adheres to the back of the upper arm, measuring glucose levels in the interstitial fluid. It provides real-time data to a smartphone app, helping users with prediabetes or non-insulin-treated type 2 diabetes monitor their metabolic health without the need for prescriptions or fingersticks.
The Dexcom Stelo CGM marks a revolution in over-the-counter glucose monitoring. As a wearable biosensor cleared by the FDA for adults not using insulin, it provides 24/7 insight into metabolic health. By providing continuous biofeedback every 15 minutes, the Dexcom Stelo CGM allows users to visualize how specific foods, exercise, and sleep habits cause glucose excursions. This real-time insight into glycemic variability enables more informed lifestyle adjustments to prevent blood sugar spikes. The system is intended to support metabolic optimization and preventive wellness through adherence monitoring rather than for making independent medical treatment decisions.
Understanding the Biosensor: Beyond Traditional Fingersticks
For years, the gold standard for tracking blood sugar was the painful fingerstick, which provided only a single snapshot in time. The Dexcom Stelo CGM changes the paradigm by utilizing an interstitial fluid sensor that stays in constant contact with your body. Instead of measuring capillary blood, this wearable biosensor tracks glucose levels in the fluid surrounding your cells. This transition from reactive medical intervention to a proactive behavioral tool is a cornerstone of preventive wellness.
The Dexcom Stelo CGM was cleared by the FDA on March 5, 2024, becoming the first continuous glucose monitor available in the United States without a prescription. This regulatory milestone allows individuals to address insulin resistance before it progresses into a more severe clinical condition. By identifying which meals cause significant blood sugar spikes, users can engage in Dexcom Stelo for non-insulin Type 2 diabetes management with unprecedented precision.
The benefits of over-the-counter glucose monitoring with Stelo extend to anyone interested in metabolic optimization. When you can see a glucose excursion in real-time, the connection between a refined carbohydrate and your body’s response becomes undeniable. This immediate feedback loop is far more effective at driving habit change than a quarterly lab test.
Stelo CGM Setup Guide and Data Integration
Setting up the device is designed to be frictionless, removing the clinical barriers often associated with medical tech. This Stelo CGM setup guide for new users highlights the simplicity of the process:
- Preparation: Clean a small area on the back of your upper arm with an alcohol wipe.
- Application: Use the auto-applicator to deploy the sensor. The tiny, flexible filament is inserted just under the skin.
- Activation: Pair the sensor with the Stelo app via Bluetooth.
- Warm-up: Wait for the 30-minute warm-up period to complete before data begins to flow.
Each 15-day sensor replacement and wear tips are essential for maintaining data accuracy. In a clinical study assessing the device's longevity, 77.9% of Dexcom Stelo sensors successfully lasted for the full intended 15-day wear period. To maximize your sensor life, ensure the adhesive is pressed firmly and avoid snagging the device on tight clothing.
Once the Stelo CGM setup guide is complete, the digital health platform begins translating raw data into actionable insights. The app focuses on glycemic variability—the "ups and downs" of your sugar levels throughout the day. By observing how exercise flattens a spike or how poor sleep increases your baseline, you receive real-time biofeedback that empowers better daily choices.
Stelo vs. Dexcom G7: Which Is Right for You?
While the hardware is similar to the flagship Dexcom G7, the Stelo is streamlined for a different audience. The primary difference lies in the software and the intended user. Stelo is an alert-free experience, meaning it won’t wake you up at 3:00 AM with hypoglycemia alarms. This reduces alarm fatigue for those who are not at immediate risk of dangerous low blood sugar.
| Feature | Dexcom Stelo CGM | Dexcom G7 |
|---|---|---|
| Prescription Required | No (Over-the-Counter) | Yes |
| Target Audience | Non-insulin users (Type 2, Prediabetes) | Type 1, Type 2 on insulin |
| Age Requirement | 18+ years | 2+ years |
| Sensor Life | 15 Days | 10 Days (+ 12h grace period) |
| Hypoglycemia Alerts | No | Yes (Real-time alerts) |
| Data Sharing | Limited (Personal use focus) | Extensive (Dexcom Share/Follow) |
For many seeking non-insulin glucose tracking, the Stelo is the superior choice because it emphasizes metabolic health trends rather than acute medical crises. It acts more like a fitness tracker for your internal chemistry, facilitating adherence monitoring for lifestyle goals.
Financial Planning: Cost, HSA, and Insurance
Accessibility is a major factor in the success of this device. Following its commercial launch in August 2024, the Dexcom Stelo reached approximately 140,000 users and generated $22 million in revenue by the end of the year. This rapid adoption is partly due to its clear pricing model.
The system is generally sold as a two-pack (one month's supply) for around $99. Because it is an over-the-counter glucose monitoring tool, it is usually not covered by traditional health insurance or Medicare. However, using HSA or FSA to pay for Dexcom Stelo is a viable and popular option for many users. This allows you to use pre-tax dollars to invest in your metabolic optimization, making the monthly cost more manageable for long-term use.
The Catch: Safety and Limitations
While the Dexcom Stelo CGM is a powerful tool for using Stelo CGM for prediabetes lifestyle changes, it is not a universal solution. It is explicitly cleared for adults who do not use insulin. Because the device does not feature low blood sugar alerts, it is not safe for Type 1 diabetics or anyone prone to problematic hypoglycemia.
Users should also be aware of potential skin irritation from the medical-grade adhesive. While the sensor is water-resistant up to 8 feet for 24 hours, it is vital to monitor the application site for any signs of localized infection. Furthermore, this device is a tool for lifestyle adjustment; it is not meant for making independent medical treatment decisions. Always consult with a healthcare professional before making significant changes to your medication or diet based on the sensor data.
FAQ
What is the Dexcom Stelo glucose monitor?
It is the first FDA-cleared, over-the-counter continuous glucose monitor designed for non-insulin users. It uses a small wearable sensor to track glucose levels in the interstitial fluid every 15 minutes, sending data directly to a smartphone app.
Do you need a prescription for Dexcom Stelo?
No. Unlike previous versions of CGMs, the Stelo is available for direct-to-consumer purchase online and does not require a doctor's prescription.
How much does the Dexcom Stelo cost?
A one-month supply, which includes two 15-day sensors, typically costs about $99. Pricing may vary slightly depending on subscription options or bulk purchases.
How does Dexcom Stelo differ from the Dexcom G7?
The Stelo lasts 15 days instead of 10 and does not provide real-time hypoglycemia (low blood sugar) alerts. It is designed for lifestyle and metabolic health tracking, whereas the G7 is a medical-grade device for those who must manage insulin dosing.
Is Dexcom Stelo covered by insurance or Medicare?
Generally, no. Since it is an over-the-counter product, insurance and Medicare do not typically provide coverage. However, it is fully eligible for purchase using funds from Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA).
Can people with Type 1 diabetes use the Stelo CGM?
No. The Dexcom Stelo CGM is not intended for people with Type 1 diabetes or those who use insulin, as it lacks the critical low-sugar alerts necessary for safe management of those conditions.
